CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access

B New changes expected to deliver significant client savings while maintaining rigorous clinical standards WOONSOCKET, R.I., May 5, 2026 /PRNewswire/ — CVS Health (NYSE: CVS)…
posteditor
posteditor
Articles: 21727